Our study indicates that the elevated Lp-PLA2 level is not only strongly associated with ACI, but is also an independent risk factor for AIS, suggesting that serum Lp-PLA2 can be a potential early biomarker for the prediction and diagnosis of AIS. This evidence concerns the gene PLA2G7 and androgen insensitivity syndrome.